Impel Pharmaceuticals
Jerry joins Impel with over 25 years of commercial, market access and trade experience including managed care, sales, and training. Previously, he served as vice president of market access and trade at Esperion Therapeutics, Inc. and was integral in building out a new commercial department. Jerry gained the majority of his experience working with small to medium-sized specialty pharmaceutical companies including Forest Pharmaceuticals Inc., Kos Pharmaceuticals Inc., American Regent/Luitpold Pharmaceuticals Inc., Auxilium Pharmaceuticals, Inc., and Aralez Pharmaceuticals, Inc.
He offers a wealth of experience with specific strengths in building commercial organizations, developing payer/access and contracting strategies, and working cross functionally to accomplish strategic and corporate milestones.
Jerry resides in Chicago and holds a BS in Marketing from Northern Illinois University.
This person is not in any offices
Impel Pharmaceuticals
Impel NeuroPharma, Inc., is a privately-held, Seattle-based company devoted to creating life-changing, innovative therapies for central nervous system (CNS) diseases. Impel's products are based on a novel nasal drug delivery platform, the POD™ device, that administers drug to the upper nasal cavity in a consistent and predictable manner.